Form 4: Procter & Gamble Executive Balaji Purushothaman Reports Stock Option Grant and Beneficial Ownership Changes
SEC Form 4 Filing
Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, reports the acquisition of stock options and changes in beneficial ownership of company stock.
Summary
- Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble, filed a Form 4 with the SEC on October 3, 2024.
- The report details transactions related to Procter & Gamble common stock and stock options.
- On October 1, 2024, Purushothaman acquired 31,659 stock options with an exercise price of $173.04, exercisable from October 1, 2027, and expiring on September 29, 2034.
- The filing also indicates Purushothaman directly owns 11,565.9989 shares of Procter & Gamble common stock.
- Additionally, 4,494.3805 shares are indirectly owned through a retirement plan trustee.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't convey any positive or negative sentiment about the company's performance or prospects.
Positives
- The acquisition of stock options aligns the executive's interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings and transactions of company insiders. This filing is typical for executives receiving stock options as part of their compensation package.
Comparison to Industry Standards
- Stock option grants are a common component of executive compensation packages in large, publicly traded companies like Procter & Gamble.
- The vesting schedule (exercisable after three years) and expiration date (ten years from grant date) are fairly standard terms for stock options.
- Comparing the size of the grant to grants received by executives at peer companies such as Unilever or Nestle would provide further context.
Stakeholder Impact
- The stock option grant aligns the executive's interests with shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock option acquisition and transaction date. |
| 10/01/2027 | Date the stock options become exercisable. |
| 09/29/2034 | Expiration date of the stock options. |
| 10/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.